{"result": "(\"entity\"<|>GENERALITAT VALENCIANA<|>ORGANIZATION<|>Generalitat Valenciana is the regional government of Valencia responsible for health and nutrition policies.)\n##\n(\"entity\"<|>VALENCIA<|>GEO<|>Valencia is a city in Spain where the Generalitat Valenciana is located and where the referenced manual was published.)\n##\n(\"entity\"<|>CMAJ<|>ORGANIZATION<|>CMAJ is the Canadian Medical Association Journal, which publishes research and reviews on clinical nutrition and health.)\n##\n(\"entity\"<|>ASPEN<|>ORGANIZATION<|>ASPEN is the American Society for Parenteral and Enteral Nutrition, which provides guidelines for nutritional support in patients.)\n##\n(\"entity\"<|>CROHN'S DISEASE<|>EVENT<|>Crohn's disease is a type of inflammatory bowel disease that affects the gastrointestinal tract and is discussed in the context of nutritional management.)\n##\n(\"entity\"<|>NUTRITIONAL THERAPY<|>EVENT<|>Nutritional therapy refers to the dietary management and treatment of patients with inflammatory bowel diseases, including Crohn's disease.)\n##\n(\"entity\"<|>JPEN<|>ORGANIZATION<|>JPEN is the Journal of Parenteral and Enteral Nutrition, which publishes research related to nutritional therapy.)\n##\n(\"entity\"<|>GASTROENTEROLOGY<|>ORGANIZATION<|>Gastroenterology is a medical journal that publishes research on digestive diseases, including inflammatory bowel disease.)\n##\n(\"entity\"<|>NUTR CLIN<|>ORGANIZATION<|>Nutr Clin is a journal that focuses on clinical nutrition and its applications in health care.)\n##\n(\"entity\"<|>ALIMENT PHARMACOL THER<|>ORGANIZATION<|>Aliment Pharmacol Ther is a journal that publishes articles on the pharmacological aspects of nutrition and diet in health and disease.)\n##\n(\"relationship\"<|>GENERALITAT VALENCIANA<|>VALENCIA<|>Generalitat Valenciana is the governing body located in Valencia, responsible for health policies in the region<|>8)\n##\n(\"relationship\"<|>CMAJ<|>NUTRITIONAL THERAPY<|>CMAJ publishes research articles related to clinical nutrition, including management of nutritional problems in diseases like Crohn's<|>7)\n##\n(\"relationship\"<|>ASPEN<|>NUTRITIONAL THERAPY<|>ASPEN provides guidelines for nutritional therapy in patients, which is relevant to the management of Crohn's disease<|>8)\n##\n(\"relationship\"<|>JPEN<|>NUTRITIONAL THERAPY<|>JPEN publishes research on parenteral and enteral nutrition, which is crucial for managing patients with Crohn's disease<|>8)\n##\n(\"relationship\"<|>GASTROENTEROLOGY<|>CROHN'S DISEASE<|>Gastroenterology publishes research on Crohn's disease and its treatment, including nutritional aspects<|>7)\n##\n(\"relationship\"<|>NUTR CLIN<|>CROHN'S DISEASE<|>Nutr Clin publishes articles on clinical nutrition, including the management of Crohn's disease<|>7)\n##\n(\"relationship\"<|>ALIMENT PHARMACOL THER<|>CROHN'S DISEASE<|>Aliment Pharmacol Ther discusses dietary management and pharmacological interventions in Crohn's disease<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Interna. 2004; \n    21:212-4.\n---\nTema 30. Soporte nutricional en la enfermedad inflamatoria intestinal 495\n\n32. Mesejo A, Blasco ML, Giménez, Gimeno V, Oliver V, Peña A. Enfermedad inflamatoria intestinal. Mesejo A. Manual de nutrición. Valencia. Editorial. Generalitat Valenciana Conselleria Sanitat. 2000. 171-75.\n\n33. Ortega R M. Alimentos probióticos. Viabilidad de las bacterias del yogur y leches fermentadas. Nutr Clin. 2004; 24: 141-49.\n\n34. Jeejeebhoy KN. Clnical nutrition 6.Management of nutritional problems of patients with Crohn's disease. CMAJ 2002; 166 (7):913-18\n\n35. Gassull MA. Review article: the role of nutrition in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20 (Suppl.4): 79-83.\n\n36. Butler CC, Vidal-Alaball J, Cannings-John R, McCaddon A, Hood K, Papaioannou A, McDowell I and Goringe A. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials. Family Practice 2006; 23: 279-85.\n\n37. Kim SC, Ferry GD. Inflammatory Bowel Disease in Pediatric and Adolescent Patients. Gastroenterology 2004; 126 (6): 1550-60.\n\n38. ASPEN. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN 2007; 26: 73SA-74SA.\n\n39. Wędrychowicz A, Zając A, Tomasik P. Advances in nutritional therapy in inflammatory bowel diseases: review. World J Gastroenterol. 2016; 22:1045-66.\n\n40. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Da ase Syst Rev 2007; CD000542.\n\n41. The Use of Enteral Nutrition in the Management of Crohn's Disease in Adults/D; Phillipe Marteau JPEN, Journal of Parenteral and Enteral Nutrition; Jul/Aug 2005; 29, 4; ProQuest Medical Library pg. S166.\n\n42. Cabré E, Gassull MA. Nutrición en la enfermedad inflamatoria intestinal. En: Gil A, editor. Tratado de Nutrición. Nutrición Clínica (vol. 4). Madrid: Grupo Acción Médica; 2005. p.881-906.\n\n43. Fernández-Bañares F, Cabré E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing remission in active Crohn's disease? A meta-analysis of the randomised clinical trials. JPEN 1995; 19:356-64.\n\n44. Richman E, Rhodes JM. Review article: evidence-based dietary advice for patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013; 38:1156-71.\n\n45. González-Huix F, Fernández Bañares F, Esteve Comas M, Abad Lacruz A, Cabré E, Acero D y cols. Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis. Am J Gastroenterol 1993; 88:227-32.\n\n46. Sakurai T, Matsui T, Yao T, et al.: Short-Term Efficacy of Enteral Nutrition in the Treatment of Active Crohn's Disease: A Randomized, Controlled Trial Comparing Nutrient Formulas. JPEN 2002; 26 (Nº 2): 98-103.\n\n47. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007.\n\n48. Llor X, Pons E, Roca A, Alvarez M, Mañé J, Fernández-Bañares F, Gassull MA. The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes.Clin Nutr. 2003 Feb; 22 (1):71-9.\n\n49. The Anti-Inflammatory Effects of Enteral Nutrition/ Discussion Ian R Sanderson; Nicholas M Croft JPEN, Journal of Parenteral and Enteral Nutrition; Jul/Aug 2005; 29, 4; ProQuest Medical Library pg. S1.\n\n50. Campos FG, Waitzberg DL, Texeira MG, Mucerino DR, Kiss DR and Habr-Gama A: Pharmacological Nutrition in Inflammatory Bowel Diseases. Nutr Hosp, 2003; (18): 57-64.\n\n51. Falk J, Carleton B, Gerber P. Formulas containing live probiotic bacteria .Am J Clin Nutr. 2004 Sep; 80(3):783; 783-4.\n\n52. Philipsen-Geerling BJ, Brummer RJM. Nutrition in Crohn's disease. Clin Nutr Metab Care 2000; 3:305-309.\n\n53. Pearson M, Teahon K, Levi AJ, Bjarnason I. Food intolerance and Crohn's disease.\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}